Comparative effectiveness of high-dose versus standard-dose influenza vaccination on numbers of US nursing home residents admitted to hospital: a cluster-randomised trial

The Lancet Respiratory Medicine

Volumn 5, Issue 9, 2017, Pages 738-746

  Gravenstein, Stefan ^a,b,c,g   Davidson, H Edward ^d   Taljaard, Monica ^e,f   Ogarek, Jessica ^b   Gozalo, Pedro ^b,g   Han, Lisa ^d   Mor, Vincent ^b,g  

^a BROWN UNIVERSITY   (United States)

^b BROWN UNIVERSITY   (United States)

^c CASE WESTERN RESERVE UNIVERSITY   (United States)

^d Insight Therapeutics   (United States)

^e OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^f UNIVERSITY OF OTTAWA   (Canada)

^g PROVIDENCE VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE;

AGED; ARTICLE; CLINICAL OUTCOME; CLUSTER ANALYSIS; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; DRUG DOSE COMPARISON; DRUG MEGADOSE; FACTORIAL DESIGN; FLU LIKE SYNDROME; HEALTH CARE FACILITY; HEALTH PROGRAM; HUMAN; INFECTION RISK; INFLUENZA; INFLUENZA VACCINATION; LUNG DISEASE; MAJOR CLINICAL STUDY; MALE; MEDICARE; NONHUMAN; NURSING HOME PATIENT; OPEN STUDY; OUTCOME ASSESSMENT; PATIENT CARE PLANNING; PRIORITY JOURNAL; PRIVATE HEALTH INSURANCE; RANDOMIZED CONTROLLED TRIAL; RISK REDUCTION; SINGLE BLIND PROCEDURE; UNITED STATES; FEMALE; HOSPITALIZATION; NURSING HOME; PROCEDURES; STATISTICS AND NUMERICAL DATA; VACCINATION; VERY ELDERLY;

AGED; AGED, 80 AND OVER; CLUSTER ANALYSIS; COMPARATIVE EFFECTIVENESS RESEARCH; FEMALE; HOSPITALIZATION; HUMANS; INFLUENZA VACCINES; INFLUENZA, HUMAN; MALE; NURSING HOMES; SINGLE-BLIND METHOD; UNITED STATES; VACCINATION;

EID: 85025149141     PISSN: 22132600     EISSN: 22132619     Source Type: Journal    
DOI: 10.1016/S2213-2600(17)30235-7     Document Type: Article

References (30)

1. Thompson, WW, Shay, DK, Weintraub, E, et al. Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA 289 (2003), 179–186.
2. Thompson, WW, Shay, DK, Weintraub, E, et al. Influenza-associated hospitalizations in the United States. JAMA 292 (2004), 1333–1340.
3. National Center for Health Statistics. Health, United States, 2015: with special feature on racial and ethnic health disparities, 2016, US Government Printing Office, Hyattsville, MD.
4. Levant, S, Chari, K, DeFrances, CJ, Hospitalizations for patients aged 85 and over in the United States, 2000–2010, 2015, National Center for Health Statistics, Hyattsville, MD.
5. Hayward, AC, Harling, R, Wetten, S, et al. Effectiveness of an influenza vaccine programme for care home staff to prevent death, morbidity, and health service use among residents: cluster randomised controlled trial. BMJ, 333, 2006, 1241.
6. Deguchi, Y, Nishimura, K, Efficacy of influenza vaccine in elderly persons in welfare nursing homes: reduction in risks of mortality and morbidity during an influenza A (H3N2) epidemic. J Gerontol A Biol Sci Med Sci 56 (2001), M391–M394.
7. Pop-Vicas, A, Rahman, M, Gozalo, PL, Gravenstein, S, Mor, V, Estimating the impact of influenza vaccination on nursing home residents' morbidity and mortality. J Am Geriatr Soc 63 (2015), 1798–1804.
8. Mor, V, Intrator, O, Feng, Z, Grabowski, DC, The revolving door of rehospitalization from skilled nursing facilities. Health Aff (Millwood) 29 (2010), 57–64.
9. Rahman, M, Grabowski, DC, Gozalo, PL, Thomas, KS, Mor, V, Effect of hospital-SNF referral linkages on rehospitalization. Health Serv Res 48 (2013), 1898–1919.
10. McLaughlin, JM, McGinnis, JJ, Tan, L, Mercatante, A, Fortuna, J, Estimated human and economic burden of four major adult vaccine-preventable disease in the United States, 2013. J Prim Prev 36 (2015), 259–273.
11. Phrommintikul, A, Kuanprasert, S, Wongcharoen, W, Kanjanavanit, R, Chaiwarith, R, Sukonthasarn, A, Influenza vaccine reduces cardiovascular events in patients with acute coronary syndrome. Eur Heart J 32 (2011), 1730–1735.
12. Jefferson, T, Di Pietrantonj, C, Al-Ansary, LA, Ferroni, E, Thorning, S, Thomas, RE, Vaccines for preventing influenza in the elderly. Cochrane Database Syst Rev, 2, 2010 CD004876.
13. Beyer, WE, McElhaney, J, Smith, DJ, Monto, AS, Nguyen-Van-Tam, JS, Osterhaus, AD, Cochrane re-arranged: support for policies to vaccinate elderly people against influenza. Vaccine 31 (2013), 6030–6033.
14. Grohskopf, LA, Sokolow, LZ, Broder, KR, et al. Prevention and control of seasonal influenza with vaccines. MMWR Recomm Rep 65 (2016), 1–54.
15. DiazGranados, CA, Dunning, AJ, Jordanov, E, Landolfi, V, Denis, M, Talbot, HK, High-dose trivalent influenza vaccine compared to standard dose vaccine in elderly adults: safety, immunogenicity and relative efficacy during the 2009–2010 season. Vaccine 31 (2013), 861–866.
16. DiazGranados, CA, Dunning, AJ, Kimmel, M, et al. Efficacy of high-dose versus standard-dose influenza vaccine in older adults. N Engl J Med 371 (2014), 635–645.
17. Izurieta, HS, Thadani, N, Shay, DK, et al. Comparative effectiveness of high-dose versus standard-dose influenza vaccines in US residents aged 65 years and older from 2012 to 2013 using Medicare data: a retrospective cohort analysis. Lancet Infect Dis 15 (2015), 293–300.
18. Nace, DA, Lin, CJ, Ross, TM, Saracco, S, Churilla, RM, Zimmerman, RK, Randomized, controlled trial of high-dose influenza vaccine among frail residents of long-term care facilities. J Infect Dis 211 (2015), 1915–1924.
19. Gravenstein, S, Dahal, R, Gozalo, PL, et al. A cluster randomized controlled trial comparing relative effectiveness of two licensed influenza vaccines in US nursing homes: design and rationale. Clin Trials 13 (2016), 264–274.
20. Gozalo, PL, Pop-Vicas, A, Feng, Z, Gravenstein, S, Mor, V, Effect of influenza on functional decline. J Am Geriatr Soc 60 (2012), 1260–1267.
21. Mor, V, Gruneir, A, Feng, Z, Grabowski, DC, Intrator, O, Zinn, J, The effect of state policies on nursing home resident outcomes. J Am Geriatr Soc 59 (2011), 3–9.
22. Begg, MD, Parides, MK, Separation of individual-level and cluster-level covariate effects in regression analysis of correlated data. Stat Med 22 (2003), 2591–2602.
23. Dahal R, Davidson HE, Han LF, Ogarek JA, Mor V, Gravenstein S. The impact of free staff influenza vaccination on the rates of vaccination of health care personnel in U.S. nursing homes: 2013–14 influenza season. Academy Health Annual Research Meeting; Minneapolis, MN; June 14, 2015. Abstr 466.
24. Zou, GY, Donner, A, Extension of the modified Poisson regression model to prospective studies with correlated binary data. Stat Methods Med Res 22 (2013), 661–670.
25. Chaves, SS, Aragon, D, Bennett, N, et al. Patients hospitalized with laboratory-confirmed influenza during the 2010–2011 influenza season: exploring disease severity by virus type and subtype. J Infect Dis 208 (2013), 1305–1314.
26. Epperson, S, Blandon, L, Kniss, K, et al. Influenza activity—United States, 2013–14 season and composition of the 2014–15 influenza vaccines. MMWR Morb Mortal Wkly Rep 63 (2014), 483–490.
27. DiazGranados, CA, Robertson, CA, Talbot, HK, et al. Prevention of serious events in adults 65 years of age or older: a comparison between high-dose and standard-dose inactivated influenza vaccines. Vaccine 33 (2015), 4988–4993.
28. Shay, DK, Chillarige, Kelman, J, et al. Comparative effectiveness of high-dose versus standard-dose influenza vaccines among US Medicare beneficiaries in preventing postinfluenza death during 2012–2013 and 2013–2014. J Infect Dis 215 (2017), 510–517.
29. Centers for Disease Control and Prevention. FluView: laboratory-confirmed influenza hospitalizations. http://gis.cdc.gov/GRASP/Fluview/FluHospRates.html (accessed Dec 22, 2016).
30. Carpenter, Gl, Hastie, CL, Morris, JN, Fries, BE, Ankri, J, Measuring change in activities of daily living in nursing home residents with moderate to severe cognitive impairment. BMC Geriatr, 6, 2006, 7.